Case series and literature review on functional pulmonary atresia in neonates functional PA in neonates: case & review.

J Matern Fetal Neonatal MedFeb 15, 2026 (epub)

Yalun Qu, Shuang Yang, Yongtao Wu et al.

✦ AI-curated · Sources linked

Case in brief

This report describes five neonates diagnosed with functional pulmonary atresia, in which a structurally normal pulmonary valve fails to open. Echocardiographic findings used to support the diagnosis included diastolic retrograde flow through the valve, significant tricuspid regurgitation, marked right-heart enlargement, and subsequent restoration of forward flow. All five infants recovered antegrade pulmonary-valve flow after individualized medical management; one also required surgery as the ductus arteriosus and foramen ovale progressively closed. All were discharged successfully.

What made this case unusual

The apparent pulmonary-valve obstruction occurred despite a structurally normal valve and resolved with restoration of forward flow, distinguishing functional atresia from fixed anatomic obstruction.

Diagnostic / clinical pearl

In a neonate with absent pulmonary-valve opening, assess valve structure and Doppler flow, right-heart findings, and change on follow-up echocardiography to recognize functional rather than fixed obstruction.

Why it matters

Recognizing functional pulmonary atresia may help avoid unnecessary surgery; management in this series was individualized, with surgery needed in one infant.

Source

Published in J Matern Fetal Neonatal Med. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Pediatrics

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.